文献速递MDS 与骨髓增殖性肿瘤

Pim1基因敲除或TP-3654药理抑制可改善小鼠模型中的骨髓纤维化

Genetic ablation of Pim1 or pharmacologic inhibition with TP-3654 ameliorates myelofibrosis in murine models.
PubMed 文献 · Leukemia · 2021-11-05

骨髓纤维化(MF)是骨髓增殖性肿瘤(MPN)中最致命的类型,JAK抑制剂芦可替尼可减轻症状但不显著改善骨髓纤维化。本研究表明,Pim1基因敲除可阻断Jak2V617F和MPLW515L诱导的骨髓纤维化;第二代Pim激酶抑制剂TP-3654可显著减少白细胞增多和脾肿大、减轻骨髓纤维化,与芦可替尼联用效果更佳。

要点

  • Pim1在MPN/MF造血祖细胞中表达显著升高
  • Pim1基因敲除阻断Jak2V617F和MPLW515L诱导的骨髓纤维化
  • TP-3654与芦可替尼联用较单药更显著缩小脾脏、使白细胞计数正常化并消除骨髓纤维化

核心结论

  • Pim1在骨髓纤维化发病机制中起重要作用,TP-3654抑制Pim1可能对骨髓纤维化治疗有用。

研究设计与样本

  • 本研究为小鼠模型研究,使用Jak2V617F和MPLW515L诱导的骨髓纤维化模型。

主要发现

  • Pim1基因敲除阻断了Jak2V617F和MPLW515L诱导的骨髓纤维化。
  • TP-3654显著减少白细胞增多和脾肿大,并减轻Jak2V617F和MPLW515L小鼠模型的骨髓纤维化。
  • TP-3654与芦可替尼联用较单药更显著缩小脾脏、使白细胞计数正常化并消除骨髓纤维化。
  • TP-3654优先抑制Jak2V617F突变造血祖细胞。
  • TP-3654显著抑制Jak2V617F突变造血细胞中的mTORC1、MYC和TGF-β信号,并减少骨髓中纤维化标志物的表达。

临床怎么用

  • 作者认为,TP-3654抑制Pim1可能对骨髓纤维化治疗有用。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Myelofibrosis (MF) is the deadliest form of myeloproliferative neoplasm (MPN). The JAK inhibitor Ruxolitinib can reduce constitutional symptoms but it does not substantially improve bone marrow fibrosis. Pim1 expression is significantly elevated in MPN/MF hematopoietic progenitors. Here, we show that genetic ablation of Pim1 blocked the development of myelofibrosis induced by Jak2V617F and MPLW515L. Pharmacologic inhibition of Pim1 with a second-generation Pim kinase inhibitor TP-3654 significantly reduced leukocytosis and splenomegaly, and attenuated bone marrow fibrosis in Jak2V617F and MPLW515L mouse models of MF. Combined treatment of TP-3654 and Ruxolitinib resulted in greater reduction of spleen size, normalization of blood leukocyte counts and abrogation of bone marrow fibrosis in murine models of MF. TP-3654 treatment also preferentially inhibited Jak2V617F mutant hematopoietic progenitors in mice. Mechanistically, we show that TP-3654 treatment significantly inhibits mTORC1, MYC and TGF-β signaling in Jak2V617F mutant hematopoietic cells and diminishes the expression of fibrotic markers in the bone marrow. Collectively, our results suggest that Pim1 plays an important role in the pathogenesis of MF, and inhibition of Pim1 with TP-3654 might be useful for treatment of MF.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Dutta A, Nath D, Yang Y, et al. Genetic ablation of Pim1 or pharmacologic inhibition with TP-3654 ameliorates myelofibrosis in murine models. Leukemia. 2021. PMID: 34741118. doi:10.1038/s41375-021-01464-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。